Press Releases

RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2019 /PRNewswire/ -- Marken announced today the launch of its new marketing campaign which invites clients to think about their supply chain differently than they have in the past. The campaign illustrates how the right supply chain partner can help customers take their clinical trials, careers, therapies and companies "where they w

EXTON, Pa., Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.

BREA, Calif., Oct. 24, 2019 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2019. Envista operated as part of Danaher Corporation until its separation in September 2019.  The historical financial measures prior to the separation presented in this announcement were derived from Danaher's accounting records and a

NASHVILLE, Oct. 24, 2019 /PRNewswire/ -- SmileDirectClub, Inc. (Nasdaq: SDC) ("SmileDirectClub"), the industry pioneer and first direct-to-consumer medtech platform for teeth straightening, has announced a pilot launch of the brand's signature SmileShop experience within Shoppers Drug Mart stores, one of the most recognized and trusted names in Canadian retailing. S

SEATTLE, Wash. and VANCOUVER, British Columbia, Oct. 24, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that data from the Phase

OVERLAND PARK, Kan., Oct. 24, 2019 /PRNewswire/ -- Intouch Group, a full-service agency network serving the pharmaceutical industry, announced it is further expanding its U.S. footprint with the opening of two new offices in California. The locations include Intouch Solutions in San Francisco and Intouch Proto in

GOTHENBURG, Sweden, Oct. 24, 2019 /PRNewswire/ -- Oblique Therapeutics AB announces that Sreesha P Srinivasa is on the list of invited speakers who will be presenting at the RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020.Sreesha P Srinivasa, Senior Vice President at

New resources detail positive impact of aducanumab pivotal trial results and recent progress of ProMIS pipeline programs TORONTO and CAMBRIDGE, MA, Oct. 24, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of

CLEVELAND, Oct. 24, 2019 /PRNewswire/ -- Clinicians interested in learning more about MRI-guided radiation therapy can attend a day-long symposium on Friday, November 14, 2019 in Rome to understand the strategic, economic, clinical and technical aspects of starting an MR-image guided radiation therapy pr

Strong financials paving the way for broadening the business UPPSALA, Sweden, Oct. 24, 2019 Q3 2019 highlightsTotal net revenues of SEK 231.2 million (216.6), up 6.7 percent Zubsolv® US net revenues of SEK 182.7 million (165.4), up 10.4 percent in SEK and 3.0 p